Novartis increases stake in stem cell group – PharmaTimes

Medical Daily Novartis increases stake in stem cell groupPharmaTimesNovartis is investing a further $15 million in Israeli stem cell specialist Gamida after turning down a buyout option earlier this year. This increases Novartis' stake in the company by 2.5 percent. The investment will be used to advance Gamina's ...Novartis Will Invest another $15 Million in Gamida Cell Totaling to $50M ...Times GazetteNovartis Buys Another 2.5% In Israel's Gamida CellMedical DailyThe Ticker: Tel Aviv Shares Trade Quietly Despite UnrestHaaretz all 19 news articles
http://blog.zandcell.com/novartis-increases-stake-in-stem-cell-group-pharmatimes/